1. Home
  2. ELDN vs YOUL Comparison

ELDN vs YOUL Comparison

Compare ELDN & YOUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • YOUL
  • Stock Information
  • Founded
  • ELDN 2004
  • YOUL N/A
  • Country
  • ELDN United States
  • YOUL China
  • Employees
  • ELDN N/A
  • YOUL N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • YOUL Other Consumer Services
  • Sector
  • ELDN Health Care
  • YOUL Real Estate
  • Exchange
  • ELDN Nasdaq
  • YOUL Nasdaq
  • Market Cap
  • ELDN 164.1M
  • YOUL 131.6M
  • IPO Year
  • ELDN N/A
  • YOUL N/A
  • Fundamental
  • Price
  • ELDN $3.50
  • YOUL $1.80
  • Analyst Decision
  • ELDN Strong Buy
  • YOUL
  • Analyst Count
  • ELDN 2
  • YOUL 0
  • Target Price
  • ELDN $12.50
  • YOUL N/A
  • AVG Volume (30 Days)
  • ELDN 1.4M
  • YOUL N/A
  • Earning Date
  • ELDN 11-11-2025
  • YOUL N/A
  • Dividend Yield
  • ELDN N/A
  • YOUL N/A
  • EPS Growth
  • ELDN N/A
  • YOUL N/A
  • EPS
  • ELDN 0.21
  • YOUL N/A
  • Revenue
  • ELDN N/A
  • YOUL N/A
  • Revenue This Year
  • ELDN N/A
  • YOUL N/A
  • Revenue Next Year
  • ELDN N/A
  • YOUL N/A
  • P/E Ratio
  • ELDN $16.22
  • YOUL N/A
  • Revenue Growth
  • ELDN N/A
  • YOUL N/A
  • 52 Week Low
  • ELDN $2.32
  • YOUL N/A
  • 52 Week High
  • ELDN $5.54
  • YOUL N/A
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 70.99
  • YOUL N/A
  • Support Level
  • ELDN $2.58
  • YOUL N/A
  • Resistance Level
  • ELDN $2.71
  • YOUL N/A
  • Average True Range (ATR)
  • ELDN 0.24
  • YOUL 0.00
  • MACD
  • ELDN 0.07
  • YOUL 0.00
  • Stochastic Oscillator
  • ELDN 72.69
  • YOUL 0.00

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About YOUL Youlife Group Inc. American Depositary Shares

Youlife Group Inc is a blue-collar lifetime service provider with a nationwide network of 25 vocational schools under school management model and 25 curriculum development projects, covering a total of 37 cities or counties under 16 provinces of China.

Share on Social Networks: